New US-China Tariffs Could Affect Science

The list of imports subject to additional taxes include products used in research, but the effect of the trade dispute is still unclear.

Written byDiana Kwon
| 3 min read
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

On June 15, the Office of the United States Trade Representative released a list of 818 Chinese imports that would be subject to an additional 25 percent tariff starting on July 6. These include products used in scientific research, such as microscopes and parts used in X-rays, magnetic resonance imaging (MRI) scanners, and other imaging devices. While the effect that these tariffs will have on researchers is still unclear, some policy experts worry that President Donald Trump’s policies may impede scientific collaboration and talent flow between the two countries.

Brian Xu, a toxicologist with The Acta Group, a scientific and regulatory consulting firm, says that because China exports relatively few high-quality scientific instruments, the tariffs on those products are unlikely to have a large effect on researchers in the U.S. However, he notes that Chinese companies produce many synthetic chemicals used by pharmaceutical and biotech companies in the U.S. “If ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies